Kris Vaddi

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Kris Vaddi

Kris Vaddi is recorded as CEO at Prelude Therapeutics Inc (PRLD). Kris Vaddi has spoken on 1 earnings call across 1 company, most recently for Prelude Therapeutics Inc on November 12, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Kris Vaddi's recent earnings-call comments and cite the source calls.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Prelude Therapeutics Inc (PRLD)
CEO

Source not stated

Current

Company network

Recorded roles and call appearances connecting this person to public companies.

Prelude Therapeutics Inc

PRLD

Current role

CEO

1 appearance Latest appearance 2025-11-12

View calls and events

Leadership on record at Prelude Therapeutics Inc

Other people whose current roles at this company are on record from its filings.

Krishna Vaddi CEO, Board Member
Bryant D. Lim CFO
Julian C. Baker Board Member
Katina Dorton Board Member
Martin Babler Board Member
Paul Scherer, M.D. Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Earnings call Prelude Therapeutics Inc Q3 FY2025 Earnings Call Prelude Therapeutics Inc (PRLD)
2025-11-12